Recent publications: https://www.ncbi.nlm.nih.gov/myncbi/jung%20wook.park.2/bibliography/public/
- A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes. Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):563-572. doi: 10.1073/pnas.1915770117. Epub 2019 Dec 23. PubMed PMID: 31871155; PubMed Central PMCID: PMC6955337.
- Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Sci Transl Med. 2019 Dec 4;11(521). doi: 10.1126/scitranslmed.aax0428. PubMed PMID: 31801883; PubMed Central PMCID: PMC7238624.
- Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies. Cancer Cell. 2019 Jul 8;36(1):17-34.e7. doi: 10.1016/j.ccell.2019.06.005. PubMed PMID: 31287989; PubMed Central PMCID: PMC6703903.
- Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage. Science. 2018 Oct 5;362(6410):91-95. doi: 10.1126/science.aat5749. PubMed PMID: 30287662; PubMed Central PMCID: PMC6414229.
- A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers. Cell Rep. 2018 Sep 18;24(12):3353-3366.e5. doi: 10.1016/j.celrep.2018.08.062. PubMed PMID: 30232014; PubMed Central PMCID: PMC6382070.
- Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer. Proc Natl Acad Sci U S A. 2018 May 8;115(19):E4473-E4482. doi: 10.1073/pnas.1802354115. Epub 2018 Apr 23. PubMed PMID: 29686080; PubMed Central PMCID: PMC5949005.
- FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate. Mod Pathol. 2017 Sep;30(9):1262-1272. doi: 10.1038/modpathol.2017.44. Epub 2017 Jun 16. PubMed PMID: 28621319; PubMed Central PMCID: PMC6330177.
- Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome. Cell Rep. 2016 Dec 6;17(10):2596-2606. doi: 10.1016/j.celrep.2016.11.010. PubMed PMID: 27926864; PubMed Central PMCID: PMC5367888.
- Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay. Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4482-7. doi: 10.1073/pnas.1603645113. Epub 2016 Apr 4. PubMed PMID: 27044116; PubMed Central PMCID: PMC4843433.
- N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Cancer Cell. 2016 Apr 11;29(4):536-547. doi: 10.1016/j.ccell.2016.03.001. Epub 2016 Mar 31. PubMed PMID: 27050099; PubMed Central PMCID: PMC4829466.